logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Life Science
Filter

Life Science

Categories

Sectors

Locations

Exchange

The Yield Growth(Private)

YIELD GROWTH announces License of Extraction technology to Yield Botanicals to Establish CBD Extraction Business in the US

Sep 10, 2019

Novartis

Novartis CEO promises to speed data integrity disclosures

Sep 10, 2019

Life Science

Sumitomo Dainippon Roivant

Sumitomo Dainippon Buys 5 Roivant Companies for $3 Billion with Option to Buy 6 More

Sep 7, 2019

Life Science

Boehringer Ingelheim

Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound

Sep 7, 2019

Life Science

PAG Hisun BioRay biologics

PAG Pays $540 Million for Majority Stake in Hisun BioRay, a Biologics Company

Sep 7, 2019

Life Science

The Yield Growth(Private)

YIELD GROWTH to Present at Jefferies LLC Invitational Fitness and Wellness Summit in New York on September 12, 2019

Sep 6, 2019

Life Science

Immunotech Hong Kong IPO EAL

Beijing’s Immunotech Plans to Raise up to $200 Million in Hong Kong IPO

Sep 6, 2019

Life Science

Novartis IFM Due immunotherapies

Novartis Inks $840 Million Collaboration and Option Deal with IFM Due

Sep 6, 2019

Life Science

The Yield Growth(Private)

YIELD GROWTH Supports $3.7 Million in Licensing Deals by Adding to Product Catalogue with 26 Products In Stability Testing

Sep 5, 2019

Life Science

AstraZeneca Tagrisso (osimertinib) China

AstraZeneca’s Tagrisso Approved in China as First-Line Lung Cancer Treatment

Sep 5, 2019

Life Science

Quan Capital Zai Lab second fund

Quan Capital Closes Second Healthcare Fund at $275 Million

Sep 5, 2019

Life Science

GTEC Holdings Ltd (TSXV:GTEC)

GTEC Subsidiary Cannabis Cowboy Announces the Sale of Certain Assets and $4 Million Debt Repayment to GTEC

Sep 4, 2019

Life Science

The Yield Growth(Private)

Yield Growth Announces its Face Moisturizer with Hemp Oil Passes European Union Compliance Review and Urban Juve secures European Trademark

Sep 4, 2019

Life Science

Avalon GloboCare

Avalon GloboCare Announces $20 Million Credit Facility Provided by Company Chairman

Sep 3, 2019

Life Science

Diagnos Inc (TSXV ADK)

DIAGNOS Announces an Extension to the Diabetic Retinopathy Screening Services Assisted by Artificial Intelligence (AI) at the CHUM

Sep 3, 2019

Life Science

WELL Health Technologies Corp (TSXV WELL)

WELL Health Announces Completion of Time-Based Earn Out Payment in Connection with Previously Announced Acquisition of Private HealthCare Clinics

Aug 31, 2019

Life Science

The Yield Growth(Private)

YIELD GROWTH Signs Exclusive Distribution Agreement with Organic Medical Growth in Colombia and Brazil

Aug 29, 2019

Life Science

The Yield Growth(Private)

YIELD GROWTH Licenses European Rights for 6 CBD Formulas to Melorganics for $900,000

Aug 28, 2019

Life Science

  • ‹‹ Previous
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada